AEON.WS

AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS

Overview Fund Activity
Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-30
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
DKCM
1
Davidson Kempner Capital Management
New York
$0
2
LP
2
LMR Partners
United Kingdom
$0
3
AC
3
Athos Capital
Hong Kong
$0
4
WAM
4
Wolverine Asset Management
Illinois
$0
5
AC
5
Aristeia Capital
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
26
Clear Street
New York
– -$9.02K -6,218 Closed
UBS Group
27
UBS Group
Switzerland
– -$7.11K -4,900 Closed
LIM
28
Longfellow Investment Management
Massachusetts
– -$2.26K -1,559 Closed
RCM
29
Robinson Capital Management
Michigan
– -$735 -700 Closed
Bank of America
30
Bank of America
North Carolina
– -$4 -3 Closed
1
2